Evidence map›Paper›PMID 37240843›Full record

ReviewLife (Basel, Switzerland)2023

Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Rita Jacobs, Walter Verbrugghe, Karolien Dams, Ella Roelant, Marie Madeleine Couttenye, Dirk Devroey, Philippe Jorens

3 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06079021 narecruitingnot on this mapstarted 2024, after this paper: background citation

COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device

TypeinterventionalSponsorUniversity Hospital, AntwerpRan2024 to 2027Enrolled20ConditionsAcute-On-Chronic Liver Failure, Anticoagulant Adverse Reaction, Sarcopenia, UltrasonographyArmsCytoSorb
NCT06908746 recruitingnot on this mapstarted 2024, after this paper: background citation

Efficacy and Safety of Citrate Anticoagulation in CRRT for Patients With Liver Failure/DysfuncTION, the CAUTION Trial! A Retrospective Study on Etiology of Liver Failure and Their Complications

TypeobservationalSponsorUniversity Hospital, AntwerpRan2024 to 2025Enrolled100ConditionsLiver Failure, AKI - Acute Kidney Injury
NCT07514650 narecruitingnot on this mapstarted 2024, after this paper: background citation

Validation of a Regional Citrate Anticoagulation Protocol in Critically Ill Patients on Continuous Renal Replacement Therapy

TypeinterventionalSponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauRan2024 to 2026Enrolled43ConditionsAcute Kidney Injury, ICU Patients, Continuous Renal Replacement Therapy (CRRT), ElectrolytesArmscontinuous renal replacement therapy
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Guideline
  2. [S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Guideline
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Nutrition support for patients with renal dysfunction in the intensive care unit: A narrative review.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2025
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rita JacobsIntensive Care Department, Antwerp University Hospital, 2650 Edegem, Belgium.
Walter VerbruggheIntensive Care Department, Antwerp University Hospital, 2650 Edegem, Belgium.
Karolien DamsIntensive Care Department, Antwerp University Hospital, 2650 Edegem, Belgium.
Ella RoelantClinical Trial Center (CTC), Antwerp University Hospital, 2650 Edegem, Belgium.
Marie Madeleine CouttenyeDepartment of Nephrology and Hypertension, Antwerp University Hospital, 2650 Edegem, Belgium.ORCID 0000-0003-0324-2171
Dirk DevroeyDeparmtment of Family Medicine and Chronic Care, Faculty of Medicine and Framacy, Vrije Universiteit Brussels (VUB), 1090 Brussels, Belgium.ORCID 0000-0002-6083-2998
Philippe JorensIntensive Care Department, Antwerp University Hospital, 2650 Edegem, Belgium.ORCID 0000-0002-5434-957X
Antwerp University Hospital · BEVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnticoagulation is recommended to maintain the patency of the circuit in continuous renal replacement therapy (CRRT). However, anticoagulation-associated complications can occur. We performed a systematic review and meta-analysis to compare the efficacy and safety of citrate anticoagulation to heparin anticoagulation in critically ill patients treated with CRRT.

methodsRandomised controlled trials (RCTs) evaluating the safety and efficacy of citrate anticoagulation and heparin in CRRT were included. Articles not describing the incidence of metabolic and/or electrolyte disturbances induced by the anticoagulation strategy were excluded. The PubMed, Embase, and MEDLINE electronic databases were searched. The last search was performed on 18 February 2022.

resultsTwelve articles comprising 1592 patients met the inclusion criteria. There was no significant difference between the groups in the development of metabolic alkalosis (RR = 1.46; (95% CI (0.52-4.11);

conclusionregional citrate anticoagulation is a safe anticoagulant for critically ill patients who require CRRT, as no significant differences were found in metabolic complications between the groups. Additionally, citrate has a lower risk of bleeding and circuit loss than heparin.

Indexed as

anticoagulationcitratecontinuous renal replacement therapyfilter lifespanheparinmetabolic complications

Identifiers

PMID37240843
PMCPMC10221969
OpenAlexW4377107724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.